19-08-15	Viscogliosi Brothers LLC cancelled the acquisition of OP-1 Portfolio Program from Ember Therapeutics, Inc..	CI
18-08-15	Viscogliosi Brothers LLC entered into a letter of intent to acquire OP-1 Portfolio Program from Ember Therapeutics, Inc..	CI
16-09-07	Ember Therapeutics, Inc. acquired the assets of of Dermasilk Brands, Inc. from Midwood Distributors, Inc. for $1.3 million.	CI
16-07-06	Knight Therapeutics Inc. and Ember Therapeutics, Inc. Expand Distribution Partnership	CI
16-03-20	Ember Therapeutics, Inc. entered into a definitive agreement to acquire the assets of Migralex, Inc. for $0.87 million.	CI
16-03-15	Ember Therapeutics, Inc. acquired ICX-RHY/Vavelta from Intercytex Limited for $1.1 million.	CI
16-02-24	American Home Alliance Corp will Change its Ticker to EMBT from AHLL	CI
16-02-24	AMERICAN HOME ALLIANCE CORP will Change its Name to Ember Therapeutics, Inc	CI
16-02-02	Ember Therapeutics, Inc. acquired American Home Alliance Corp. in a reverse merger transaction.	CI
15-10-19	Ember Therapeutics, Inc. Announces Initial Positive Results from a Phase 2 Trial of BMP-7	CI
15-03-11	Mariel Therapeutics, Inc. acquired Ember Therapeutics, Inc. from Third Rock Ventures II, L.P. of Third Rock Ventures II, L.P. and others for $6 million.	CI
14-12-30	Ember Therapeutics, Inc. acquired Worldwide License of BMP-7 and OP-1 Portfolio from Stryker Corporation.	CI
12-09-27	Ember Therapeutics, Inc. Announces Publication of Key Preclinical Data Demonstrating Inhibition of Transient Receptor Potential Vanilloid	CI

22-05-29	Alternative Liquidity Index LP Announces an Extension of the Tender Offer for Ember Therapeutics, Inc.	AQ
21-11-18	Moore Kuehn Encourages EMBT, VSAT, IHC and CSPR Investors to Contact Law Firm	PR

Company Profile

Employees

Sector